Here we demonstrate that serum uPAR level positively correlates with the percentage of lung involvement in COVID-19 patients (Figure 2), serving to predict lung damage >25% (Figure 3), and is independently associated with COVID-19-related lung damage severity (OR 1.219 [1.016–1.498]) (Figure 4). This evidence concerns the gene PLAUR and COVID-19.